Jacqueline Cloos

15.7k total citations · 1 hit paper
203 papers, 8.7k citations indexed

About

Jacqueline Cloos is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jacqueline Cloos has authored 203 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 94 papers in Hematology and 48 papers in Oncology. Recurrent topics in Jacqueline Cloos's work include Acute Myeloid Leukemia Research (76 papers), Acute Lymphoblastic Leukemia research (37 papers) and Ubiquitin and proteasome pathways (34 papers). Jacqueline Cloos is often cited by papers focused on Acute Myeloid Leukemia Research (76 papers), Acute Lymphoblastic Leukemia research (37 papers) and Ubiquitin and proteasome pathways (34 papers). Jacqueline Cloos collaborates with scholars based in Netherlands, United States and Germany. Jacqueline Cloos's co-authors include Gertjan J.L. Kaspers, Johan van Meerloo, Gerrit Jansen, Yehuda G. Assaraf, Gerrit Jan Schuurhuis, Sonja Zweegman, Godefridus J. Peters, Boudewijn J.M. Braakhuis, Denise Niewerth and Anna Wojtuszkiewicz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jacqueline Cloos

194 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell Sensitivity Assays: The MTT Assay

2011 1.9k citations Johan van Meerloo, Gertjan J.L. Kaspers et al. profile →

Peers

Countries citing papers authored by Jacqueline Cloos

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Cloos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Cloos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Cloos more than expected).

Fields of papers citing papers by Jacqueline Cloos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Cloos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Cloos. The network helps show where Jacqueline Cloos may publish in the future.

Co-authorship network of co-authors of Jacqueline Cloos

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Cloos. A scholar is included among the top collaborators of Jacqueline Cloos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Cloos. Jacqueline Cloos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia 2025 ·HemaSphere ·(unknown), Arjan A. van de Loosdrecht, Jacqueline Cloos, Costa Bachas	2
2	The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells 2024 ·Cytometry Part B Clinical Cytometry ·(unknown), (unknown), Lok Lam Ngai, (unknown), (unknown), Willemijn J. Scholten, Angèle Kelder, Diana Hanekamp, (unknown), Noortje van Gils, Patrycja Gradowska, Bob Löwenberg, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Theresia M. Westers, Linda Smit, Costa Bachas, Jacqueline Cloos	3
3	Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia 2024 ·Leukemia ·Jesse M. Tettero, (unknown), (unknown), (unknown), Angèle Kelder, Willemijn J. Scholten, Alexander N. Snel, Lok Lam Ngai, Costa Bachas, Arjan A. van de Loosdrecht, Gert J. Ossenkoppele, David C. de Leeuw, Jacqueline Cloos, Jeroen J. W. M. Janssen	8
4	Immunophenotypic features of early haematopoietic and leukaemia stem cells 2024 ·International Journal of Laboratory Hematology ·(unknown), Costa Bachas, Jacqueline Cloos	5
5	Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Róbert de Jonge, (unknown), (unknown), (unknown), Eduard A. Struys, Cees B.M. Oudejans, Yehuda G. Assaraf, Jacqueline Cloos, Amaya Puig‐Kröger, Gerrit Jansen	4
6	Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel 2023 ·American Journal of Hematology ·Farhad Ravandi, Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman, Christopher S. Hourigan, G. J. Ossenkoppele, Gail J. Roboz, Marion Subklewe, Christian Thiede, (unknown), Peter J.M. Valk, Adriano Venditti, Andrew H. Wei, Roland B. Walter, Michael Heuser	10
7	Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication 2022 ·Cancer Drug Resistance ·(unknown), Costa Bachas, Linda Smit, Jacqueline Cloos	8
8	Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML 2021 ·Cancers ·Anna Wojtuszkiewicz, Inge van der Werf, Stephan Hütter, Wencke Walter, Constance Baer, Wolfgang Kern, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Claudia Haferlach, Jacqueline Cloos, Torsten Haferlach	4
9	SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia 2021 ·Leukemia ·Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, Rocco Sciarrillo, Manja Meggendorfer, Stephan Hütter, Wencke Walter, Jeroen J. W. M. Janssen, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gerrit Jansen, Gertjan J.L. Kaspers, Richard W.J. Groen, Gert J. Ossenkoppele, Jacqueline Cloos	8
10	Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification 2021 ·Blood Advances ·Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hütter, Constance Baer, Martijn W. Heymans, Peter J.M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach	23
11	Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines 2020 ·Molecular & Cellular Proteomics ·(unknown), Jacqueline Cloos, Robin Beekhof, (unknown), Sander R. Piersma, Jaco C. Knol, Alex A. Henneman, Thang V. Pham, Johan van Meerloo, Gert J. Ossenkoppele, Henk M.W. Verheul, Jeroen J. W. M. Janssen, Connie R. Jiménez	30
12	Minimal residual disease and stem cell transplantation outcomes 2019 ·Hematology ·Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon	11
13	Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma 2018 ·EBioMedicine ·Rocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, Niccola Funel, Paolo Gandellini, Tonny Lagerweij, Silvia Buonamici, (unknown), (unknown), Nadia Zaffaroni, Marcello Deraco, Shigeki Kusamura, Tom Würdinger, Godefridus J. Peters, Carla F.M. Molthoff, Gerrit Jansen, Gertjan J.L. Kaspers, Jacqueline Cloos, Elisa Giovannetti	47
14	EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System 2015 ·Molecular Cancer Research ·Kim R. Kampen, Frank J.G. Scherpen, Guillermo Garcia‐Manero, Huixin Yang, Gertjan J.L. Kaspers, Jacqueline Cloos, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink, Steven M. Kornblau, Eveline S.J.M. de Bont	19
15	Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia 2011 ·Haematologica ·Brian V. Balgobind, Iris H.I.M. Hollink, Susan T.C.J.M. Arentsen-Peters, M Zimmermann, Jochen Harbott, H. Berna Beverloo, Anne R. M. von Bergh, Jacqueline Cloos, Gertjan J.L. Kaspers, Válerie de Haas, Zuzana Zemanová, Jan Starý, J M Cayuela, André Baruchel, Ursula Creutzig, Dirk Reinhardt, R. Pieters, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink	76
16	Immunophenotypic patterns of childhood acute leukemias in Indonesia. 2011 ·PubMed ·Eddy Supriyadi, (unknown), A. Veerman, (unknown), Yetty Movieta Nency, (unknown), (unknown), Dewajani Purnomosari, (unknown), Guus Westra, (unknown), Jacqueline Cloos	7
17	High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia 2010 ·Blood ·Hendrik J.M. de Jonge, Peter J.M. Valk, Nic J.G.M. Veeger, Arja ter Elst, Monique L. den Boer, Jacqueline Cloos, Válerie de Haas, Marry M. van den Heuvel‐Eibrink, Gertjan J.L. Kaspers, C. Michel Zwaan, Willem A. Kamps, Bob Löwenberg, Eveline S.J.M. de Bont	74
18	Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes 2006 ·Molecular Cancer Research ·Jacqueline Cloos, (unknown), Mireille H.J. Snel, Paul van den IJssel, Bauke Ylstra, C. René Leemans, Ruud H. Brakenhoff, Boudewijn J.M. Braakhuis	28
19	Human Lymphoblastoid Proteome Analysis Reveals a Role for the Inhibitor of Acetyltransferases Complex in DNA Double-Strand Break Response 2006 ·Cancer Research ·(unknown), Jacqueline Cloos, Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff, Albert J. R. Heck, Monique Slijper	12
20	Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance–associated protein 1 and provokes high levels of cross‐resistance to glucocorticoids 2006 ·Arthritis & Rheumatism ·Ruud Oerlemans, (unknown), (unknown), Ben A. C. Dijkmans, Gertjan J.L. Kaspers, Willem F. Lems, George L. Scheffer, Ilan Ifergan, Rik J. Scheper, Jacqueline Cloos, Yehuda G. Assaraf, Gerrit Jansen	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact